ARCHIVES

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

This article is from The Cancer Letter archive.

Vol. 17 No. 29 | July 19, 1991

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

NCI Programs: First Raid Awardees, Drug Development Projects, Listed

March 26, 1999